Dr. Florou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2000 Circle of Hope Dr
Salt Lake City, UT 84112Phone+1 610-202-1638- Is this information wrong?
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolChief Residency, Internal Medicine, 2015 - 2016- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2012 - 2015
University of Patras School of MedicineClass of 2010
Certifications & Licensure
UT State Medical License 2019 - 2026
MT State Medical License 2021 - 2025
NV State Medical License 2021 - 2025
ID State Medical License 2021 - 2024
WY State Medical License 2021 - 2024
NJ State Medical License 2015 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Durable response to first-line PARP inhibition in-mutated metastatic cholangiocarcinoma: case report.Smith, J., Sama, S., Florou, V., Nevala-Plagemann, C., Garrido-Laguna, I.> ;Journal of Gastrointestinal Oncology. 2023 Dec 31
- 3 citationsReal-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational bur...Vaia Florou, Charalampos S Floudas, Asaf Maoz, Abdul Rafeh Naqash, Carter Norton, Aik Choon Tan, Ethan S Sokol, Garrett Frampton, Heloisa P Soares, Sonam Puri, Umang S...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
- 7 citationsSafety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
- Join now to see all
Lectures
- Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis.2019 ASCO Annual Meeting - 6/1/2019
- Angiosarcoma treated with checkpoint inhibitors: A single-institution experience.2019 ASCO Annual Meeting - 6/1/2019
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
